Inspire Medical Systems, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 13.45K shares, a 77.25% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 31.81K shares, a 79.08% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 44.51K shares, a 49.61% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 73.67K shares, a 16.58% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 163.44K shares, a 57.86% decline from fiscal 2024.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 387.86K shares, a 34.83% decline from fiscal 2023.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 595.19K shares, a 42.87% increase from fiscal 2022.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 416.60K shares, a 28.64% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 13.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 163.44K shares 10-K · filed 2026-02-13 |
| 2025-09-30 | 31.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 209.11K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | 44.51K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 329.40K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | 73.67K shares 10-Q · filed 2025-05-05 | 373.22K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | 59.11K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 387.86K shares 10-K · filed 2026-02-13 |
| 2024-09-30 | 152.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 565.44K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | 88.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 485.97K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | 88.31K shares 10-Q · filed 2024-05-07 | 541.33K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | 236.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 595.19K shares 10-K · filed 2026-02-13 |
| 2023-09-30 | 72.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 535.70K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | 143.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | 498.89K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | 142.17K shares 10-Q · filed 2023-05-02 | 407.58K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | 177.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | 416.60K shares 10-K · filed 2025-02-10 |
| 2022-09-30 | 35.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 294.04K shares derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | 52.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 344.69K shares derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | 151.19K shares 10-Q · filed 2022-05-03 | 341.63K shares derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | 54.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | 323.86K shares 10-K · filed 2024-02-09 |
| 2021-09-30 | 86.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 399.56K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | 49.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 482.06K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | 133.42K shares 10-Q · filed 2021-05-04 | 503.59K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | 130.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | 624.32K shares 10-K · filed 2023-02-10 |
| 2020-09-30 | 168.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | 548.31K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | 70.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 511.03K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | 254.14K shares 10-Q · filed 2020-05-05 | 818.67K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | 54.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 664.62K shares 10-K · filed 2022-02-15 |
| 2019-09-30 | 131.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 684.21K shares derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | 378.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 573.23K shares derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | 100.09K shares 10-Q · filed 2019-05-07 | |
| 2018-12-31 | 73.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | 301.06K shares 10-K · filed 2021-02-24 |
| 2018-09-30 | 20.71K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | |
| 2017-12-31 | 127.12K shares 10-K · filed 2020-02-25 | |
| 2016-12-31 | 109.08K shares 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |